Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Pancreatic Neoplasms 1Obesity 1Metabolic Syndrome 1Inflammation 1Dyslipidemias 1Diabetes Mellitus, Type 2 1

Interventions

Blood Specimen Collection 5Surveys and Questionnaires 3exemestane 2Tirzepatide 2Tamoxifen 2Observation 2Esophagectomy 2Biopsy 2BaseLine dental cement 2Bariatric Surgery 2Anastrozole 2semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Utrogestan 1Urine Specimen Collection 1Topiramate 1Testosterone 1Stents 1Qsymia 1Phentermine 1Naltrexone 1Metabolic Networks and Pathways 1Medical History Taking 1Mammography 1Liraglutide 1Letrozole 1Hematologic Tests 1Gonadotropin-Releasing Hormone 1Glucose Tolerance Test 1Glucagon-Like Peptide-1 Receptor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Obesity × Liraglutide × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡